These included LPS/IL-1 mediated inhibition of RXR function, TNFR2 signaling, metastasis signaling, and tumor-promoting inflammation signaling such as that mediated by IL-10, IL-6, and NF-κB (all P < 0.001) (Figure 3B). Here, IL1B is linked to neoplasm.